Provided by Tiger Fintech (Singapore) Pte. Ltd.

Annexon, Inc.

2.64
+0.05001.93%
Post-market: 2.700.0600+2.27%19:50 EDT
Volume:763.93K
Turnover:2.03M
Market Cap:289.65M
PE:-2.27
High:2.74
Open:2.61
Low:2.57
Close:2.59
Loading ...

Annexon Biosciences: Promising Developments and Strategic Milestones Justify Buy Rating

TIPRANKS
·
08 Mar

Promising Developments in Annexon Biosciences’ Pipeline Drive Buy Rating

TIPRANKS
·
04 Mar

Promising Potential of Annexon Biosciences’ ANX1502 Drives Buy Rating Amid Positive Clinical Data

TIPRANKS
·
04 Mar

Annexon price target lowered to $20 from $30 at H.C. Wainwright

TIPRANKS
·
04 Mar

Annexon Price Target Maintained With a $16.00/Share by Needham

Dow Jones
·
04 Mar

Strategic Advancements and Financial Stability Drive Buy Rating for Annexon Biosciences

TIPRANKS
·
04 Mar

Wells Fargo Reaffirms Their Buy Rating on Annexon Biosciences (ANNX)

TIPRANKS
·
04 Mar

Annexon Biosciences Reports Strong Progress in 2024

TIPRANKS
·
04 Mar

Annexon Q4 EPS $(0.33) vs $(0.36) YoY

Benzinga
·
03 Mar

Annexon Biosciences Q4 Basic EPS USD -0.33

THOMSON REUTERS
·
03 Mar

Annexon Biosciences Q4 Operating Expenses USD 52.479 Million

THOMSON REUTERS
·
03 Mar

Annexon Reports Fourth Quarter and Year-End 2024 Financial Results, Portfolio Progress and Key Anticipated Milestones

GlobeNewswire
·
03 Mar

Annexon Biosciences to Present at the TD Cowen 45th Annual Health Care Conference

GlobeNewswire
·
27 Feb

Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
18 Feb

Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
18 Feb

Annexon Announces Presentations Highlighting ANX007 Functional and Structural Differentiation in Geographic Atrophy at the Macula Society 48th Annual Meeting

GlobeNewswire
·
13 Feb

Analysts’ Top Healthcare Picks: Annexon Biosciences (ANNX), Immunovant (IMVT)

TIPRANKS
·
15 Jan

BRIEF-Annexon Provides 2025 Outlook With Strong Momentum Accelerating Into Breakthrough Year

Reuters
·
13 Jan

Annexon Provides 2025 Outlook With Strong Momentum Accelerating Into Breakthrough Year

THOMSON REUTERS
·
13 Jan

Annexon Provides 2025 Outlook with Strong Momentum Accelerating into Breakthrough Year

GlobeNewswire
·
13 Jan